Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Faisalabad Initiative of Research and Management of NCDs

NCT07676214 is registered in ClinicalTrials.gov with Getz Pharma as lead sponsor.

NCT NCT07676214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07676214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Faisalabad Initiative of Research and Management of NCDs
Lead sponsor
Getz Pharma
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
December 31, 2027
Enrollment
3,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabete mellitus, hypercholerolemia, hypertension, obesity (disorder)